SIMULTANEOUS LIGATION OF CD5 AND CD28 ON RESTING LYMPHOCYTES-T INDUCES T-CELL ACTIVATION IN THE ABSENCE OF T-CELL RECEPTOR/CD3 OCCUPANCY

被引:0
|
作者
VERWILGHEN, J
VANDENBERGHE, P
WALLAYS, G
DEBOER, M
ANTHONY, N
PANAYI, GS
CEUPPENS, JL
机构
[1] CATHOLIC UNIV LEUVEN,DEPT INTERNAL MED,DIV CLIN IMMUNOL,B-3000 LOUVAIN,BELGIUM
[2] GUYS HOSP,DEPT MED,DIV RHEUMATOL,LONDON SE1,ENGLAND
[3] INNOGENET,DEPT IMMUNOL,GHENT,BELGIUM
来源
JOURNAL OF IMMUNOLOGY | 1993年 / 150卷 / 03期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The T cell surface molecules CD5 and CD28 have been shown to be receptors for accessory signals in T cell activation. We here demonstrate that in the absence of any other activating stimulus, simultaneous ligation of CD5 and CD28 by mAb induces polyclonal T cell activation. Immobilization of the anti-CD28 and anti-CD5 mAb was an essential requirement for T cell stimulation. This was done either through coating of the culture plates with goat anti-mouse Ig, or by coculture with mitomycin C-treated FcgammaR-bearing P815 mouse mastocytoma cells. Most importantly, T cells could also be stimulated with B7, the natural ligand of CD28, and anti-CD5 presented on irradiated 3T6 mouse fibroblasts co-transfected with human FcgammaRII and with B7. Neither immobilized mAb 9.3 (anti-CD28) nor any of four different anti-CD5 mAb were mitogenic as a sole stimulus. Immobilized mAb identifying CD4, CD7, or LFA-1 were not co-mitogenic with either mAb 9.3 or one of the anti-CD5 mAb. The T cell proliferation induced by cross-linking of CD5 and CD28 is IL-2-dependent, as was demonstrated by the cell-surface expression of the p55 chain of the IL-2R, the production of IL-2, and the inhibition of the proliferative response by the anti-IL-2R mAb anti-Tac. CD5/CD28 ligation induced production of TNF-alpha, but not of IL-4, and did not induce modulation of the TCR/CD3 complex. Expression of IL-2R (p55) and of CD69 preferentially occurred on CD29-low naive cells, and indicated that about 50% of the cultured cells were activated. Cell proliferation was not increased by adding monocytes to the cultures and it was inhibited by PKC inhibitors (H7 and staurosporine) and by cyclosporine A. In conclusion, our data provide evidence for a pathway of Ag-independent T cell activation via CD5 and CD28, which preferentially stimulates naive T cells.
引用
收藏
页码:835 / 846
页数:12
相关论文
共 50 条
  • [21] CD3 × CD28 cross-interacting bispecific antibodies improve tumor cell dependent T-cell activation
    An Willems
    Steve Schoonooghe
    Dominique Eeckhout
    Geert De Jaeger
    Johan Grooten
    Nico Mertens
    Cancer Immunology, Immunotherapy, 2005, 54 : 1059 - 1071
  • [22] THE CD2 ANTIGEN ASSOCIATES WITH THE T-CELL ANTIGEN RECEPTOR CD3 ANTIGEN COMPLEX ON THE SURFACE OF HUMAN LYMPHOCYTES-T
    BROWN, MH
    CANTRELL, DA
    BRATTSAND, G
    CRUMPTON, MJ
    GULLBERG, M
    NATURE, 1989, 339 (6225) : 551 - 553
  • [23] ASSEMBLY OF THE T-CELL RECEPTOR CD3 COMPLEX
    TERHORST, C
    ALARCON, B
    BERKHOUT, B
    BLUMBERG, R
    CLEVERS, H
    GEORGOPOULOS, K
    HALL, C
    LEY, S
    SANCHO, J
    VERSTEEGEN, J
    WILEMAN, T
    PROGRESS IN IMMUNOLOGY, VOL 7, 1989, : 33 - 39
  • [24] T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28
    Renner, C
    Ohnesorge, S
    Held, G
    Bauer, S
    Jung, W
    Pfitzenmeier, JP
    Pfreundschuh, M
    BLOOD, 1996, 88 (01) : 236 - 241
  • [25] STRUCTURE OF THE T-CELL ANTIGEN RECEPTOR - EVIDENCE FOR 2 CD3 EPSILON-SUBUNITS IN THE T-CELL RECEPTOR CD3 COMPLEX
    BLUMBERG, RS
    LEY, S
    SANCHO, J
    LONBERG, N
    LACY, E
    MCDERMOTT, F
    SCHAD, V
    GREENSTEIN, JL
    TERHORST, C
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) : 7220 - 7224
  • [26] CD5(-) CD56(+) T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas
    Emile, JF
    Boulland, ML
    Haioun, C
    Kanavaros, P
    Petrella, T
    DelfauLarue, MH
    Bensussan, A
    Farcet, JP
    Gaulard, P
    BLOOD, 1996, 87 (04) : 1466 - 1473
  • [27] Inhibition of T-cell activation by CD28 and CD40L blockade is influenced by T-cell precursor frequency.
    Ford, Mandy
    Koehn, Brent
    Waener, Maylene
    Borom, Keshowna
    Gangappa, Shivaprokosh
    Pearson, Thomas
    Larsen, Christian
    CLINICAL IMMUNOLOGY, 2006, 119 : S100 - S101
  • [28] CD28 signaling in neutrophil induces T-cell chemotactic factor(s) modulating T-cell response
    Venuprasad, K
    Chattopadhyay, S
    Saha, B
    HUMAN IMMUNOLOGY, 2003, 64 (01) : 38 - 43
  • [29] In vitro CD4+ T-cell expansion: induction of regulatory T-cells with sirolimus and CD3/CD28 dynabeads
    Borelli, G.
    Aarvak, T.
    Brunsvig, A.
    Rasmussen, A.
    Kvalheim, G.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S226 - S226
  • [30] CD28: beyond just T-cell costimulation
    Li, Xian C.
    Sayegh, Mohamed H.
    BLOOD, 2007, 109 (07) : 2668 - 2669